TGFB1 and IL8 gene polymorphisms and susceptibility to visceral leishmaniasis
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
19/10/2012
19/10/2012
2011
|
Resumo |
Visceral leishmaniasis (VL) or Kala-azar is a serious protozoan infectious disease caused by an obligate intracellular parasite. Cytokines have a major role in determining progression and severity of clinical manifestations in VL. We investigated polymorphisms in the TGFB1 and IL8 genes, which are cytokines known to have a role in onset and severity of the disease. Polymorphisms at TGFB1 -509 C/T and +869 T/C, and IL8 -251 A/T were analyzed by a PCR-RFLP technique, in 198 patients with VL, 98 individuals with asymptomatic infection positive for a delayed-type hypersensitivity test (DTH+) and in 101 individuals with no evidence of infection (DTH-). The presence of the T allele in position -509 of the TGFB1 gene conferred a two-fold risk to develop infection both when including those with clinical symptoms (DTH+ and VL, grouped) or when considering DTH+ only, respectively p = 0.007, OR = 1.9 [1.19-3.02] and p = 0.012, OR = 2.01 [1.17-3.79], when compared with DTH- individuals. In addition, occurrence of hemorrhage was associated with TGFB1 -509 T allele. We suggest that the -509 T allele of the TGFB1 gene, a cytokine with a biologically relevant role in the natural history of the disease, may contribute to overall susceptibility to infection by Leishmania and to severity of the clinical disease. (C) 2011 Elsevier B.V. All rights reserved. Brazilian National Research Council (CNPq) CAPES CNPq |
Identificador |
INFECTION GENETICS AND EVOLUTION, v.11, n.5, p.912-916, 2011 1567-1348 http://producao.usp.br/handle/BDPI/23306 10.1016/j.meegid.2011.02.014 |
Idioma(s) |
eng |
Publicador |
ELSEVIER SCIENCE BV |
Relação |
Infection Genetics and Evolution |
Direitos |
restrictedAccess Copyright ELSEVIER SCIENCE BV |
Palavras-Chave | #Visceral leishmaniasis #Cytokines #Gene polymorphisms #Disease susceptibility #GROWTH-FACTOR-BETA #CHAGASI INFECTION #INTERFERON-GAMMA #AMPHOTERICIN-B #KALA-AZAR #ASSOCIATION #PROMOTER #INTERLEUKIN-10 #BRAZIL #MACROPHAGES #Infectious Diseases |
Tipo |
article original article publishedVersion |